Class I · High riskTerminated Initiated Dec 17, 2019 (7 years ago)
Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray…
Class I — High risk. Reasonable probability of serious harm or death.
Why it was recalled
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
What was recalled
Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX
Recalling firm
Motto International Corp
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0656-2020
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.